Respiratory testing once followed a familiar rhythm in the lab: Ramp up for peak season, scale back when volume drops, and plan inventory accordingly. But post-pandemic, those default cycles shifted, extending demand for sampling materials beyond traditional yearly timelines.
That means long-standing assumptions around inventory planning have become less reliable. Today’s lab leaders must navigate a more fluid environment where timing is uncertain, and supply decisions carry greater operational consequences.
As a result, shelf life has taken on a more central role in inventory strategy. The amount of usable time attached to a product now directly impacts how well labs can plan stock levels, respond to fluctuations, and maintain diagnostic readiness across more variable testing patterns.
Preparedness isn’t seasonal: Moving away from typical surge timelines
Respiratory testing demand no longer follows the clean, seasonal arc seen pre-2020. While winter still brings higher numbers, slower periods are shorter and less consistent, with intermittent spikes. And now that COVID circulates alongside cold and flu, our baseline has risen. Operationally, the year now looks like rolling phases instead of a single peak:
- The baseline: Steadier, lower-level testing outside of peak season
- Early signals: Public health alerts or regional case increases preceding broader surges
- Surge response: Rapid volume increases requiring immediate access to usable inventory
When preparedness can’t hinge on a defined respiratory season, shelf-life becomes more consequential in inventory management.
Longer-dated supplies have a wider margin to carry through quieter periods without constant turnover pressure, enabling more reserve capacity that remains viable whenever demand accelerates.
It also provides a critical advantage when early surge signals appear. Upon a public health alert, labs often scramble to secure additional materials before the wave hits. Meanwhile, every other lab does the same. When supply chains tighten amid the rush, inventory with extended life offers a buffer before replenishment.
Shelf-life distorts the math behind inventory planning
Shelf-life directly influences how labs plan, purchase, and manage testing supplies, and tight expiration timelines can muddy those decisions. Past seasons’ numbers are helpful in estimating need but can lead to excess or shortfalls as volume patterns change.
Lab managers should consider how shelf-life plays into:
- Frequency: Short-dated inventory must be replenished more often, increasing purchasing cycles and administrative burden. Adjusting in shorter intervals instead of maintaining a stable inventory position strains budgets and workflows.
- Timing: Product age determines how much value it ultimately delivers. In many cases, a portion of its usable life has already elapsed before it reaches the lab or distributor. This reduces the window for effective use and compresses planning.
The challenge amplifies among labs that distribute to external partners. Leaders must also account for how much shelf-life remains when supplies reach the patient, ensuring they stay viable across the full chain of use.
Together, these factors move inventory planning from a straightforward stocking exercise to a balancing act, making shelf-life a main planning consideration.
Waste matters, but readiness matters more
Many lab leaders view expired inventory solely through the lens of cost. Discarded supplies drive wasted spend, and reducing that loss is still a priority. But focusing on waste alone overlooks a more pressing concern: having the right materials ready when needed.
Short shelf-life can create a constant cycle of assessing what to keep, ship, and hold in reserve. Without clear visibility, allocating supplies becomes more difficult across internal operations and external distribution.
And when demand for respiratory sampling spikes, the stakes further increase. It's imperative to return test results to the patient within 72 to 96 hours of symptom onset. Beyond that, treatment has minimal impact on health outcomes.
A shortage of specimen collection materials can postpone therapeutic intervention while slowing testing workflows. Not only does this disrupt timely care and increase disease exposure for technicians, but it also puts public health at risk and distorts the broader containment picture.
Advanced Lab Management Certificate
The Advanced Lab Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
What lab leaders should weigh when evaluating shelf-life
The goal is to keep enough inventory on hand to cover the baseline without burning money on excess reserves. With the recently altered surge timelines in mind, lab managers should frame year-round inventory planning around key questions like:
- How much shelf-life remains at not just point of receipt, but the estimated point of use?
- How often will this item require repurchasing under normal demand?
- How much excess buffer is needed to protect against spikes?
- Will this inventory be used internally only or distributed onward?
- How does shelf-life interact with storage burden, waste exposure, and surge readiness?
Artificial intelligence advancements have also started enabling more data-informed forecasting. AI-assisted planning can now spot supply chain gaps and reduce guesswork in inventory projections one, five, or even 10 years down the road.
The objective isn’t to replace existing processes with new tools, but to strengthen them by layering more advanced analysis with historical data. In practice, AI can refine strategies to help labs:
- View multi-year demand data instead of only the previous season
- Adjust quantities based on baseline shifts, not just peak periods
- Build earlier reorder triggers when public health signals or trends indicate surges
- Continually seek updated data to inform projections, especially with newer-to-market products.
Balancing readiness, excess, and real-world demand drivers for strategic year-round planning
Effectively preparing without overstocking remains one of the most complex challenges facing modern laboratories. The answer isn’t to simply maximize supply, but to stock enough usable inventory to respond promptly without too much excess hurting the bottom line.
While many labs approach this balance using default inputs like past usage and projected volumes, inventory management isn't homogenous. Some of the most impactful variables are localized or patient-specific, which often aren’t reflected in standard forecasting models.
To further enhance decision-making, lab leaders should also consider:
- Regional trends: National averages don’t always match local realities. Analyze testing patterns in your specific region, especially as respiratory activity becomes less geographically uniform.
- Patient population mix: Demand can vary based on end-user demographics. Clients supporting higher-risk populations, like elderly or pediatric patients, may require more consistent access, higher volumes, or faster turnover than others.
- Use-case segmentation: Don’t stop at product type. Reserve longer-dated inventory for external partners and allocate shorter-dated materials for more predictable, internal use.
- Response time buffers: Beyond volume, also account for how long it takes to replenish supply to bridge operation gaps between early surge signals and inventory arrival.
As respiratory testing needs stray from historical routines, longer shelf-life provides more flexibility to carry inventory with confidence and nimbly adjust. Shorter-dated products leave little room for such variability.
The lab leaders who succeed will start viewing shelf-life less as a background specification and more as a strategic planning factor—one that shapes how inventory is built, maintained, and deployed across both baseline demands and rapid surges.
